Original Article
Print
Original Article
Evaluation of the relationship between insulin resistance and 8-iso prostaglandin levels in obesity children
expand article infoIlter Demirhan, Erkan Oner§, Ergul Belge Kurutas|
‡ Harran University, Sanliurfa, Turkiye
§ Adıyaman University, Adıyaman, Turkiye
| Sutcu Imam University, Kahramanmaras, Turkiye
Open Access

Abstract

Introduction: The rising rate of childhood obesity and the serious health problems it causes are gaining increasing attention in medical research and health policy.

Aim: This study aimed to evaluate the relationship between insulin resistance and the oxidative stress biomarker 8-iso-prostaglandin F levels in obese children.

Materials and methods: Forty-four children in total (21 boys and 23 girls) aged between 6 and 15 years and diagnosed with obesity who attended the Pediatric Endocrinology Unit between December 2020 and June 21 were enrolled in our study. Forty children (20 boys and 20 girls) without systemic diseases were selected as controls. From the percentile curves determined for Turkish children, percentile values of obese children and control group were calculated based on sex and age. In addition, the insulin resistance values (HOMA-IR) in the homeostasis model were calculated. The relationship between the variables was examined with the Pearson and Spearman correlation tests. Children between the 5th and 85th percentile were defined as the control group, and those above the 95th percentile were defined as the obese group. Systolic and diastolic blood pressure, triglyceride, total cholesterol, LDL cholesterol, HDL cholesterol, fasting blood sugar (glucose), insulin, and 8-iso-PGF concentrations were measured in all children included in the study.

Results: There were significant differences between the two groups in terms of age, body mass index, and systolic and diastolic blood pressures (p<0.05). Glucose, triglyceride, insulin, 8-iso-PGF and HOMA-IR levels were found to be statistically significantly higher in obese children than the levels in the control group (p<0.05). In addition, significant positive correlations were found between insulin levels and glucose, triglyceride and HOMA-IR values in obese patients (p<0.05). In obese children, 8-iso-PGF concentrations were found to be statistically significantly higher than those in the control group (p<0.01). ROC analysis had a good diagnostic value for 8-iso-PGF where the area under the curve was 1.0. A direct, positive, statistically significant correlation was found between insulin resistance and the 8-iso-PGF values (r=0.420, p=0.037).

Conclusions: 8-iso-PGF concentrations were found to be higher in obese children than in the control group. It was observed that increased insulin resistance raised 8-iso-PGF levels. 8-iso-PGF is thought to be particularly important for the diagnosis and treatment of these patients, with 99% sensitivity and specificity.

Keywords

8-iso-PGF, childhood obesity, oxidative stress, pediatric

Introduction

Obesity is defined as an increase in energy intake over energy expenditure and an increase in fat tissue in the body. Excessive energy intake causes the accumulation of adipose tissue in the body. Today, obesity is considered among the diseases that carry the most important risk of mortality and morbidity, together with the complications it brings. The World Health Organization (WHO) has ranked obesity in first place among the most important diseases.[1] It is known that obesity causes a number of diseases, such as cardiovascular diseases, insulin resistance, oxidative stress, and dyslipidemia. An increased body mass index (BMI) poses a serious risk to body health, and those with a BMI above 30 are considered obese. Obesity directly leads to insulin resistance, increasing insulin levels in the blood.[2] The need for more insulin to produce a normal biological response is called insulin resistance. Insulin resistance has been demonstrated in almost all type 2 diabetes patients.[3]

Obesity has become a major health concern for both children and adults as a result of factors such as improved economic conditions, increased consumption of ready-made foods in recent years, children spending more time at home due to technological advancements, shrinking playgrounds, and climate change.[4] According to some reports, one-third of obese children grow up to be obese adults. Furthermore, different disorders are observed in these people at an adult age. One of the issues that the health community is most concerned about is the fact that childhood obesity will rise in the twenty-first century.[5]

Obesity has become more prevalent in Western societies, according to studies conducted on children aged 6 to 19.[6] While the prevalence of being overweight is 13.9% on average in the children of our country, it has been reported that the average prevalence of obesity is 4.8%.[7] However, a study on children in Turkey found that obesity was increasing in both sexes.[8] Childhood obesity can be said to be attributed to genetic and familial factors, psychological factors, a sedentary lifestyle, and poor eating habits.[9] Fatigue, difficulty in breathing, and extremity pain are observed in very few of obese children. It is observed that they have a high appetite, they eat carbohydrate and fat-based diets, and they are reluctant to consume fruit and vegetables.[10]

Reactive oxygen species (ROS) play a role in the pathophysiology of many diseases, including cardiovascular diseases, obesity, type 2 diabetes, and atherogenic mechanisms. It is stated that oxidative stress is associated with the formation of adipose tissue, which contributes to the development of obesity and metabolic syndrome.‌[10] The level of antioxidant capacity decreases with obesity and the increase in adipose tissue.[11] In obesity, mechanical work force and myocardial mechanism increase and oxygen consumption accelerates. Increasing oxygen consumption accelerates the formation of ROS.[12] Isoprostanes are products formed by the nonenzymatic peroxidation of polyunsaturated fatty acids such as arachidonic acid induced by free radicals. Isoprostane and prostaglandins are called 8-iso prostaglandin F because they are isomers of prostaglandin F formed by cyclooxygenase.[13] 8-iso-PGF has been measured as an indicator of lipid peroxidation in various body fluids such as urine, blood, bile, pericardial fluid, cerebrospinal fluid, and in tissues such as the brain and liver.[14] 8-iso-PGF, an indicator of oxidative stress and lipid peroxidation, has been studied in cardiovascular diseases, lung diseases and neurodegenerative diseases.[15]

Aim

The study aimed to evaluate the relationship between insulin resistance and the oxidative stress biomarker 8-iso-PGF levels in obese children in our country where parent-child association is high.

Materials and methods

The study included 44 children, 21 boys and 23 girls, between the ages of 6 and 15, with obesity-related diagnoses who attended the Faculty of Medicine Pediatric Endocrinology Department at Kahramanmaras Sutcu Imam University between December 2020 and June 2021. The control group consisted of 40 children (20 boys and 20 girls) who were free of any systemic diseases.

Collection and storage of samples

Venous blood samples taken from the children in the patient and control groups in the morning after 8-12 hours of fasting were placed in tubes that did not contain anticoagulant substances. Then, the blood samples were centrifuged at 4000 rpm for ten minutes and their serum was separated with a Hettich centrifuge device. Glucose, triglyceride, total cholesterol, HDL cholesterol, and insulin analyses were performed. Furthermore, a sufficient amount of serum samples were separated for 8-iso PGF analysis and stored in a deep freezer at −80°C until analysis.

Anthropometric measurements

Systolic and diastolic blood pressure measurements were made with an Oncomed brand sphygmomanometer on the right arm in a sitting position after 10 minutes of rest. Using height and weight measurements, percentile values of the control group and obese children were calculated according to sex and age. Homeostasis model assessment (HOMA) was used to determine insulin resistance.[16]

Biochemical measurements

For the analysis of serum 8-iso-PGF level, 8-iso-PGF commercial kit (Cayman, USA, catalog No. 514638.2) enzyme immunoassay method was performed by ELISA using a 50-μl sample. The measurement principle is based on competitive enzyme immunoassay. Reagents were pipetted in the indicated amounts according to the experimental procedure. After pipetting, the test plate was covered and incubated at 4ºC for 18 hours. After 18 hours, the plate was washed 5 times with the prepared washing solution. 200 µl of Ellman’s reagent solution was pipetted into all wells. The test plate was covered and incubated for 120 minutes on an orbital shaker at room temperature. At the end of the period, the test plate was read at a wavelength of 405-420 nm. The results of 8-iso-PGF were expressed as pg/ml. Moreover, glucose, triglyceride, total cholesterol, and HDL-cholesterol concentrations were measured by enzymatic colorimetric methods on a synchron LX 20 analyzer (Beckman Coulter, USA) using original Beckman kits. The LDL-cholesterol levels were calculated with the Friedewald formula as follows:

Total cholesterol (mg/dl) = HDL-cholesterol + VLDL ([Trig]/5) + LDL-cholesterol

Statistical analysis

SPSS 15.0 statistical package program was used in the statistical evaluation of the findings. Independent t-test was performed for total cholesterol and LDL cholesterol. the Mann-Whitney U test, one of the nonparametric tests, was used for parameters that did not show normal distribution (blood pressure, serum glucose, triglyceride, HDL-cholesterol, 8-iso-PGF, and HOMA-IR indices). Relationships between parameters were evaluated in pairs with the Spearman correlation analysis. A value of p<0.05 was considered statistically significant.

Results

Considering the descriptive values, when the obese child and control groups were compared, it was seen that there was no difference between the two groups in terms of sex distribution and age. It was found that the height and weight of the obese children were significantly higher than those in the control group (Table 1).

Significant differences were observed between the two groups in terms of age, body mass index, and systolic and diastolic blood pressures (p<0.05). The systolic and diastolic blood pressure of the obesity and control groups are presented in Table 7. The lipid profiles of obese children and control groups were compared and TG, TC, and LDL values were found to be significantly higher in obese children compared to the control group, while HDL values were found to be significantly lower than the respective values in the control group (Table 2).

Obese children and control groups were compared in terms of 8-iso-PGF levels which were found to be significantly higher in obese children than in the control group (Table 3).

A moderate correlation was found between HOMA and 8-iso-PGF levels in obese children (Fig. 1).

When obese children and control groups were compared in terms of BMI and 8-iso-PGF levels, BMI and 8-iso-PGF values of obese children (32.03±4.53) were found to be significantly higher (p>0.001) compared to those in the control group (17.10±2.32) (Fig. 2).

Relationships between descriptive values, routine, and biochemical parameters were also examined in all children, and accordingly, a significant positive correlation was found with children’s TG, HOMAR, BMI, glucose, LDL, TC, and 8-iso-PGF levels. HDL and insulin levels were found to be significantly negatively correlated. The Spearman correlation analysis between groups is shown in Table 4.

Since p<0.05, it was determined that the correlation coefficient was significant. Table 5 shows that 8-iso-PGF levels are highly positively correlated with the control group and obesity.

Our ROC analysis showed that the measurement of 8-iso-PGF showed a high level of accuracy (AUC=0.966) and a sensitivity of 100%, making it appropriate to trust it (Fig. 3, Table 6).

Table 1.

Descriptive values of the obese and control groups

Obese children N=44 Control group N=40
Sex 23 (G), 21 (B) 20 (G), 20 (B)
Age 10.5±4.5 10.7±3.48
Height (cm) 141.2±12.5 135.1±15.3
Weight (kg) 68.6±18.4 35.7±12.2
Table 2.

Routine values of obese and control groups

Parameters Control Obesity p
HOMAR 2.15±0.76 7.51±2.11 <0.05
BMI 17.10±2.32 32.02±4.53 <0.05
Glucose (mg/dL) 81.50±7.78 112.30±12.73 <0.05
Cholesterol 121.18±16.42 150.27±37.07 <0.05
Insulin (µU/dL) 26±8.17 15.98±7.14 <0.001
Triglyceride (mg/dL) 73.58±9.25 116.32±14.92 <0.001
HDL (mg/dL) 46.55±7.95 35.09±7.96 <0.05
LDL (mg/dL) 93.48±10.84 118.55±20.23 <0.05
Table 3.

Values of 8-iso prostaglandin belonging to the control and obese groups

Control Obesity p
8-iso prostaglandin 10.29±1.23 27.15±8.41 <0.05
Figure 1.

Relationship between HOMAR and 8-iso prostaglandin: scatter plot chart.

Figure 2.

8-iso prostaglandin boxplot plot according to BMI values.

Table 4.

Spearman correlation analysis between groups

HOMAR BMI Glucose Cholesterol Insulin Triglyceride HDL LDL ISO
HOMAR r 1.000 0.738 0.776 0.362 −0.417 0.771 0.505 0.539 0.722
p 0.006 0.007 0.001 0.004 0.007 0.004 0.004 0.003
BMI r 0.738 1.000 0.780 0.445 −0.444 0.754 −0.458 0.518 0.788
p 0.006 0.004 0.005 0.007 0.001 0.005 0.004 0.003
Glucose r 0.776 0.780 1.000 0.304 −0.426 0.694 −0.447 0.584 0.803
p 0.007 0.004 0.006 0.005 0.007 0.008 0.004 0.001
Cholesterol r 0.362 0.445 0.304 1.000 −0.364 0.441 −0.320 0.179 0.333
p 0.001 0.005 0.006 0.008 0.009 0.007 0.006 0.005
Insulin r −0.417 −0.444 −0.426 −0.364 1.000 −0.431 0.397 −0.188 −0.421
p 0.004 0.007 0.005 0.008 0.005 0.007 0.006 0.002
Triglyceride r 0.771 0.754 0.694 0.441 −0.431 1.000 −0.566 0.499 0.725
p 0.007 0.001 0.007 0.009 0.005 0.006 0.002 0.003
HDL r −0.505 −0.458 −0.447 −0.320 0.397 −0.566 1.000 −0.248 −0.439
p 0.004 0.005 0.008 0.007 0.007 0.006 0.004 0.002
LDL r 0.539 0.518 0.584 0.179 −0.188 0.499 −0.248 1.000 0.562
p 0.004 0.004 0.004 0.006 0.006 0.002 0.004 0.005
8-iso-prostaglandin r 0.722 0.788 0.803 0.333 −0.421 0.725 −0.439 −0.562 1.000
p 0.003 0.003 0.001 0.002 0.003 0.002 0.002 0.005
Table 5.

Pearson Correlations 8-Iso-prostaglandin F

Control Obesity
Control Pearson correlation 1 0.914
p 0.009
Obesity Pearson correlation 0.914 1
p 0.009
Figure 3.

ROC curves for the obesity and control dimensions of 8-iso-prostaglandin F. AUC: area under the curve; ROC: receiver-operating characteristic

Table 6.

ROC curves value for the obesity and control dimensions of 8-iso-prostaglandin F

Risk factor AUC 95% p Cut-off Sensitivity (%) Specificity
0.966 (0.927-1.00) 0.020 8.63 100 90.0
Table 7.

Mean values of systolic and diastolic blood pressure in obese and healthy children

Parameter Obesity Control p
Systolic blood pressure (Hg) 140.18±26.78 118.26±26.78 <0.05
Diastolic blood pressure (Hg) 88.16±14.78 74.32±10.48 <0.05

Discussion

Obesity is a chronic, progressive disease characterized by psychological issues that limit physical activity. The prevalence of obesity is increasing rapidly in both developing and developed countries. This disease affects children as well as adults negatively day by day. In our country, the problem of obesity has not been emphasized much; moreover, many families have adopted the view that an overweight child is healthy. Today, it is known that there is a relationship between obesity and cardiovascular diseases, type 2 diabetes, lung diseases, and neurodegenerative diseases. In addition, it is well known that obesity begins in childhood in most obese adults.[17]

Lifestyle, feeding frequency and type, child’s birth weight are the factors that should be focused on the mechanism of childhood obesity. Children born to obese parents are more likely to be obese. While the concept of obesity is taken into account in adults, it is observed that there are deficiencies in childhood obesity.[17–18] Considering that obesity is a common health problem in the society, a cost-effective and easily applicable method should be used in diagnosis and follow-up.[19] BMI values vary according to age and sex in children. Therefore, BMI percentile curves prepared for Turkish children were taken into account when determining obese and control children during the study.[20] In the study, those with 95th percentile values and above were determined as the obese group, and children between the 5th and 85th percentiles were determined as the control group. Therefore, the BMI values of the obese children were found to be higher than those of the control group. Candido et al. and Mantovani et al. obtained similar study results. We think that the BMI values of obese children are an indicator of increased adipose tissue in their bodies.[21, 22]

When obese children and control groups were compared in terms of glucose and insulin levels, there were significant differences seen in the study. In our study, glucose levels were found to be higher in the obese children group than those in the control group, while insulin levels were lower in the obesity group than in the control group. There are studies in the literature in which both insulin and glucose levels are higher in the obesity group than in the control group.[22, 23] In addition, there are studies similar to ours that evaluated significant differences between glucose levels and insulin levels.[24] Insulin sensitivity is best assessed using the clamp technique. However, the invasive nature of the clamp technique makes it difficult to use it in practice. Instead of this technique, insulin sensitivity is evaluated according to the fasting insulin values and the insulin values measured during the oral glucose tolerance test. For this purpose, the insulin sensitivity index and the HOMA index are frequently used, and these methods are reported to be correlated with the hyperglycemic clamp technique.‌[24] There are studies showing that HOMA can be used to evaluate the sensitivity of insulin resistance and can be applied precisely and easily.[25] Similarly, the HOMA index was used for IR evaluation in the study. It can be said that the increase in fat mass is a factor in the high HOMA values in obese children in the study. In addition, the lack of sufficient number of receptors despite the increase in insulin requirement can be considered as another factor.

There are studies which evaluated different plasma lipid levels in obese children. In general, studies on obese children have shown that HDL levels decrease as the degree of obesity increases. On the contrary, increases are observed in triglyceride and LDL levels.[26] Likewise, Reinehr et al. stated in their study that there were decreases in the serum HDL levels in obese children.[27] In our research, we found that the triglyceride, total cholesterol, and LDL levels were significantly higher in obese children than those values in the control group. In addition, HDL levels were observed at lower levels compared to the control group. Our research result parameters are similarly supported by the study of Boyd et al.[26] In addition, correlations between parameters were made in children and it was shown that there is a positive relationship between the triglyceride, total cholesterol, and LDL levels.

A study found that plasma 8-iso-PGF2 levels, which are used as an indicator of oxidative stress, were significantly higher in obese children than in the healthy control group. It is seen that there is a direct correlation between plasma 8-iso-PGF level and visceral adipose tissue. In addition, there was no significant correlation between subcutaneous adipose tissue and plasma 8-iso-PGF levels in non-obese children. It is stated that 8-iso-PGF is a strong and independent determinant of visceral adipose accumulation. [33] In a study including 58 patients, Kelly et al. found that the plasma 8-iso-PGF levels of obese children were higher than those in normal children. High levels of plasma 8-iso-PGF can be interpreted as the possibility of a higher incidence of type 2 diabetes and cardiovascular diseases in obese children in the future.[28] When the plasma 8-iso-PGF values are examined, it is seen that results consistent with the studies in the literature are obtained.[29–31] Many researchers have reported an increase in plasma 8-iso-PGF levels in patients with insulin resistance.[30, 31] In another study evaluating the relationship of oxidative stress with diabetes, obesity and atherosclerosis, 8-iso-PGF levels were found to be significantly higher in obese adults. In a different study investigating the relationship of oxidative stress with obesity and insulin resistance only in adult males, it was reported that 8-iso-PGF levels were higher in obese males than in normal males. [32] In the literature, it is seen that the obesity 8-iso-PGF correlation is mostly evaluated in adults. This study investigated the correlation between obesity in children and 8-iso-PGF.

The blood pressure values obtained in the study show that there is a correlation between 8-iso-PGF levels and obesity. While the mean systolic blood pressure was 140.18±26.78 mmHg in the obesity group, the mean systolic blood pressure was 118.26±26.78 mmHg in the control group. While the diastolic blood pressure was 88.16±14.78 mmHg in the children with obesity, it was 74.32±10.48 mmHg in the control group. It is known that 8-iso-PGF, which is administered endogenously into the vein, increases blood pressure. Therefore, increased 8-iso-PGF level in obese children is thought to be effective in increasing blood pressure.

Conclusions

Oxidative stress forms the infrastructure of many diseases. Today, exposure to oxidative stress due to various factors has decreased to very young ages. It has been proven by various studies that oxidative stress can disrupt the normal working principles of the energy production mechanisms in the body and affect the general working principles of the cell. In this context, understanding the metabolic and biochemical background of oxidant mechanisms in the development of diseases, interpreting their measurable results and identifying biomarkers will contribute to early diagnosis and treatment. There are many biomarkers used as indicators in oxidative stress studies. In the present study, 8-iso-PGF levels were based on as a biomarker of oxidative stress, and obese children were our area of interest. Our results showed that 8-iso-PGF concentrations were higher in obese children than in the control group. We can say that elevated 8-iso-PGF levels are related to high blood pressure and visceral adiposity. In this respect, we can say that increased levels of 8-iso-PGF, which we consider as a biomarker of oxidative stress, may be a factor in the formation of cardiovascular diseases in obese children. Furthermore, we can say that the diagnosis of the disease can be made with 99% sensitivity of 8-iso-PGF levels in obese children. As insulin resistance increased, there was an increase in the 8-iso-PGF levels suggesting that this biomarker is important in the diagnosis of obesity.

Compliance with the ethical standards

All human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. All persons gave their informed consent prior to their inclusion in the study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Funding

The authors have no funding to report.

References

  • 1. Alemzadeh R, Rising R, Lifshitz F. Pediatric endocrinology. 2nd ed. New York: Marcel Dekker; 2007: 1–52.
  • 2. Gazi M. Relationship between diabetes mellitus, microalbuminuria and waist circumference in patients with metabolic syndrome [PhD thesis] Istanbul 2007.
  • 3. Tracy RP. Is visceral adiposity the “enemy within”? Arterioscler Thromb Vasc Biol 2001; 21:881–3.
  • 4. Wethington HR, Sherry B, Polhamus B. Physician practices related to use of BMI-for-age and counseling for childhood obesity prevention: a cross-sectional study. BMC Fam Pract 2011; 12:80.
  • 5. Tasan E. Definition, evaluation methods and epidemiology of obesity. Turkey Clinics J Int Med Sci 2005; 1:1–4.
  • 6. Mokdad AH, Bowman BA, Ford ES. The continuing epidemic of obesity and diabetes in the United States. JAMA 2001; 286:1195–200.
  • 7. Bereket A, Atay Z. Current status of childhood obesity and its associated morbidities in Turkey. J Clin Res Pediatr Endocrinol 2012; 4:1–7.
  • 8. Wilde JA, Van Dommelen P, Middelkoop BJ, et al. Trends in overweight and obesity prevalence in Dutch, Turkish, Moroccan and Surinamese South Asian children in the Netherlands. Arch Dis Child 2009; 94:795–800.
  • 9. Koksal G, Special GH. Childhood and Adolescence Obesity. Ankara: Klasmat Printing; 2008; 8–9.
  • 10. Weker H. Simple obesity in children. A study on the role of nutritional factors. Med Wieku Rozwoj 2006; 10:3–191.
  • 11. Guo H, Jin D, Zhang Y. Lipocalin 2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 2010; 59:1376–85.
  • 12. Morrow JD, Harris TM, Roberts LJ. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem 1990; 184:1–10.
  • 13. Harrıson KA, Murphy RC. Isoleukotrienes are biologically active free radical products of lipid peroxidation. J Biol Chem 1995; 270:17273–8.
  • 14. Montine TJ, Beal MF, Cudkowicz ME. Increased CSF F 2-isoprostanes concentration in probable AD. Neurology 1999; 52:562–5.
  • 15. Pratico D, Delanty N. Oxidative injury in the central nervous system - focus on Alzheimer’s disease. Am J Med 2000; 109:577–85.
  • 16. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7):412–9.
  • 17. Danielzik S, Langnase K, Mast M. Impact of parental BMI on the 95 manifestation of overweight 5–7 year old children. Eur J Nutr 2002; 41:132–8.
  • 18. Steffen LM, Dai S, Fulton JE, et al. Overweight in children and adolescents associated with TV viewing and parental weight: Project Heart Beat! Am J Prev Med 2009; 37:50–5.
  • 19. Louise S, Warrington NM, McCaskie PA, et al. Associations between aggressive behaviour scores and cardiovascular risk factors in childhood. Pediatr Obes 2012; 7(4):319–28.
  • 20. Bundak R, Furman A, Günöz H, et al. Body mass index for Turkish children. Acta Pediatr 2006; 95:194–8.
  • 21. Candido APC, Alosta JPS, Oliveira CT, et al. Anthropometric methods for obesity screening in schoolchildren: the Ouro Preto Study. Nutr Hosp 2012; 27:146–53.
  • 22. Mantovani RM, Rios DRA, Moura LCR, et al. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity. J Pediatr Endocrinol Metab 2011; 24:361–7.
  • 23. Kim ES, Im JA, Kim KC, et al. Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth. Obesity (Silver Spring) 2007; 15:3023–30.
  • 24. Garber AJ. The metabolic syndrome. Med Clin North Am 2004; 88:837–46.
  • 25. Keskin M, Kurtoglu S, Kendirci M, et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115:500–3.
  • 26. Boyd GS, Koenigsberg J, Falkner B, et al. Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents. Pediatrics 2005; 116:442–6.
  • 27. Reinehr T, Kiess W, De Sousa G, et al. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006; 55:113–8.
  • 28. Kelly AS, Jacobs DR, Sinaiko AR, et al. Relation of circulating oxidized LDL to obesity and insulin resistance in children. Pediatr Diabetes 2010; 11:552–5.
  • 29. Rodrigo R, Prat H, Passalacqua W, et al. Relationship between oxidative stress and essential hypertension. Hypertens Res 2007; 30(12):1159–67.
  • 30. Schwedhelm E, Bartling A, Lenzen H, et al. Urinary 8-iso-prostaglandin F as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 2004; 110(5):49–50.
  • 31. John F, Keaney JR, Larson MG, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23:434–9.
  • 32. Reilly MP, Pratico D, Delanty N, et al. Increased formation of distinct F2-isoprostanes in hypercholesterolemia. Circulation 1998; 98:2822–8.
  • 33. Fujita K, Nishizawa H, Funahashi T, et al. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006; 70:1437–42
login to comment